Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:36:14 EST Sat 17 Jan 2026
Enter Symbol
or Name
USA
CA



Q:CODX - CO DIAGNOSTICS INC - https://www.codiagnostics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CODX - Qnot subscribed2.83-0.09-3.139.2984372.92  2.92  2.7046.50  2.3615:59:59Jan 1215 min RT 2¢

Recent Trades - Last 10 of 437
Time ETExPriceChangeVolume
15:59:59Q2.83-0.0923
15:57:22Q2.8305-0.08953
15:56:45Q2.81-0.111
15:56:45Q2.81-0.111
15:55:52Q2.85-0.072
15:55:35Q2.83-0.09197
15:55:28Q2.85-0.073
15:55:19Q2.81-0.111
15:55:07Q2.83-0.091
15:54:57Q2.81-0.111

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-12 09:00U:CODXNews ReleaseCo-Diagnostics JV CoSara Participates in Regional Conferences to Grow and Strengthen Distributor Relationships
2025-12-30 09:00U:CODXNews ReleaseCo-Diagnostics Announces Reverse Stock Split
2025-12-29 09:00U:CODXNews ReleaseCo-Diagnostics Receives Grant of Australian Patent Covering Co-Dx PCR Platform Technologies
2025-12-18 09:00U:CODXNews ReleaseCo-Diagnostics Joint Venture, CoSara, Invited to Participate in 2nd Advanced TB Diagnostics Course in Chennai, India
2025-12-17 09:00U:CODXNews ReleaseCo-Diagnostics Performs Analysis of Influenza Co-Primers(TM) to Confirm Reactivity Against Flu A H3N2 Mutation
2025-12-09 09:00U:CODXNews ReleaseCo-Diagnostics to Present on Co-Dx(TM) PCR Platform and AI Integration at Point-of-Care Testing 2025
2025-12-08 12:36U:CODXNews ReleaseCo-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India
2025-11-20 09:00U:CODXNews ReleaseCo-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health
2025-11-18 09:00U:CODXNews ReleaseCo-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx(TM) PCR Platform to Support Submission to the U.S. FDA
2025-11-13 16:01U:CODXNews ReleaseCo-Diagnostics Reports Third Quarter 2025 Financial Results
2025-11-12 09:00U:CODXNews ReleaseUtah Governor Cox and BioUtah Recognize Co-Diagnostics Following Recent JV Announcement in Kingdom of Saudi Arabia
2025-11-05 09:00U:CODXNews ReleaseCo-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics Pvt. Ltd
2025-11-03 09:00U:CODXNews ReleaseCo-Diagnostics to Integrate and Implement Proprietary Artificial Intelligence Technology into Co-Dx(TM) Primer Ai(TM) Platform
2025-10-31 09:00U:CODXNews ReleaseCo-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast
2025-10-30 13:57U:CODXNews ReleaseCo-Diagnostics to Host Fireside Chat on November 5th with CEO, Dwight Egan, to Discuss Recently Announced Definitive Agreement in Saudi Arabia
2025-10-29 12:51U:CODXNews ReleaseCo-Diagnostics, Inc. Announces Closing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
2025-10-28 09:33U:CODXNews ReleaseCo-Diagnostics, Inc. Announces Pricing of $7.0 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
2025-10-27 08:45U:CODXNews ReleaseCo-Diagnostics Signs Definitive Agreement with Arabian Eagle in the Kingdom of Saudi Arabia to Establish CoMira Diagnostics and Localize Co-Dx(TM) PCR Platform Across the Middle East
2025-10-22 08:30U:CODXNews ReleaseCo-Diagnostics Executive Leadership Team to Attend Global Health Exhibition 2025 in Riyadh, Saudi Arabia
2025-10-16 09:30U:CODXNews ReleaseCo-Diagnostics Announces Development of Proprietary Sample Prep Instrument for PoC Testing